Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 1.11 | - |
NAV | ₹10.71 | - |
Fund Started | 29 Oct 2024 | - |
Fund Size | ₹29.14 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 15 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
1.11
-
NAV
₹10.71
-
Fund Started
29 Oct 2024
-
Fund Size
₹29.14 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
Returns
1 Year | - | - |
3 Year | - | - |
5 Year | - | - |
1 Year
-
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 99.66% | - |
Cash | 0.34% | - |
Equity
99.66%
-
Cash
0.34%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Fortis Healthcare Ltd. | 9.59% |
Lupin Ltd. | 8.77% |
Laurus Labs Ltd. | 6.20% |
Alkem Laboratories Ltd. | 5.80% |
Aurobindo Pharma Ltd. | 5.75% |
Glenmark Pharmaceuticals Ltd. | 5.58% |
Mankind Pharma Ltd. | 5.22% |
Biocon Ltd. | 3.89% |
Ipca Laboratories Ltd. | 3.53% |
Krishna Institute of Medical Sciences Ltd | 3.27% |
-
Fund Manager
Name | Swapnil P Mayekar | - |
Start Date | 05 Jun 2025 | - |
Name
Swapnil P Mayekar
-
Start Date
05 Jun 2025
-
About Fund
Description | The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error. | - |
Launch Date | 29 Oct 2024 | - |
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
-
Launch Date
29 Oct 2024
-